Fluorescence in situ hybridization identifies more aggressive types of primarily noninvasive (stage pTa) bladder cancer

Journal of Urology

Volumn 157, Issue 6, 1997, Pages 2116-2119

  Pycha, Armin ^a   Mian, Christine ^a   Haitel, Andrea ^a   Hofbauer, Johann ^a   Wiener, Helene ^a   Marberger, Michael ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

bladder neoplasms; fluorescence; neoplasm staging; protein p53

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; DIAGNOSTIC VALUE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL;

EID: 0031003377     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)64690-1     Document Type: Article

References (20)

1. Soloway, M.: Managing superficial bladder cancer: an overview. Urology, suppl., 40: 5, 1992.
2. Holmäng, S., Hedelin, H., Anderström, C. and Johansson, S. L.: The relationship among multiple recurrences, progression and prognosis of patients with stages TA and T1 transitional cell cancer of the bladder followed for at least 20 years. J. Urol., 153: 1823, 1995.
3. Olumi, A. F., Tsai, Y. C., Nichols, P. W., Skinner, D. G., Cain, D. R., Bender, L. I. and Jones, P. A.: Allelic loss of chromosome 17p distinguishes high grade from low grade transitional cell carcinomas of the bladder. Cancer Res., 50: 7081, 1990.
4. Meloni, A. M., Peier, A. M., Haddad, F. S., Powell, I. J., Block, A. W., Huben, R. P., Todd, I., Potter, W. and Sandberg, A. A.: A new approach in the diagnosis and follow-up of bladder cancer. FISH analysis of urine, bladder washings, and tumors. Cancer Genet. Cytogen., 71: 105, 1993.
5. Spruck, C. H., III, Ohneseit, P. F., Gonzalez-Zulueta, M., Esrig, D., Miyao, N., Tsai, Y. C., Lerner, S. P., Schmütte, C., Yang, A. S., Cote, R., Dubeau, L., Nichols, P. W., Hermann, G. G., Steven, K., Horn, T., Skinner, D. G. and Jones, P. A.: Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res., 54: 784, 1994.
6. Ruppert, J. M., Tokino, K. and Sidransky, D.: Evidence for two bladder cancer suppressor loci on human chromosome 9. Cancer Res., 53: 5093, 1993.
7. Waldman, F. M., Carroll, P. R., Kerschmann, R., Cohen, M. B., Field, F. G. and Mayall, B. H.: Centromeric copy number of chromosome 7 is strongly correlated with tumor grade and labeling index in human bladder cancer. Cancer Res., 51: 3807, 1991.
8. Wheeless, L. L., Reeder, J. E., Han, R., O'Connell, M. J., Frank, I. N., Cockett, A. T. and Hopman, A. H.: Bladder irrigation specimens assayed by fluorescence in situ hybridization to interphase nuclei. Cytometry, 17: 319, 1994.
9. Pauwels, R. P., Schapers, R. F., Smeets, A. W., Debruyne, F. M. and Geraedts, J. P.: Grading in superficial bladder cancer. (1) Morphological criteria. Brit. J. Urol., 61: 129, 1988.
10. Thomas, D. J., Robinson, M. C., Charlton, R., Wilkinson, S., Shenton, B. K. and Neal, D. E.: p53 expression, ploidy and progression in pT1 transitional cell carcinoma of the bladder. Brit. J. Urol., 73: 533, 1993.
11. Sauter, G., Deng, G., Moch, H., Kerschmann, R., Matsumura, K., De Vries, S., George, T., Fuentes, J., Carroll, P., Mihatsch, M. J. and Waldman, F. M.: Physical deletion of the p53 gene in bladder cancer. Detection by fluorescence in situ hybridization. Amer. J. Path., 144: 756, 1994.
12. Levine, A. J., Momand, J. and Finlay, C. A.: The p53 tumor suppressor gene. Nature, 351: 453, 1991.
13. Mellon, K., Wilkinson, S., Vickers, J., Robinson, M. C., Shenton, B. K. and Neal, D. E.: Abnormalities in p53 and DNA content in transitional cell carcinoma of the bladder. Brit. J. Urol., 73: 522, 1994.
14. Mellon, K., Neal, D. E., Robinson, M. C., Marsh, C. and Wright, C.: Cell cycling in bladder carcinoma determined by monoclonal antibody Ki67. Brit. J. Urol., 66: 281, 1990.
15. Fontana, D., Bellina, M., Gubetta, L., Fasolis, G., Rolle, L., Scoffone, C., Porpiglia, F., Colombo, M., Tarabuzzi, R. and Leonardo, E.: Monoclonal antibody Ki-67 in the study of the proliferative activity of bladder carcinoma. J. Urol., 148:1149, 1992.
16. Hermanek, P. and Sobin, L. H.: UICC TNM Classification of Malignant Tumours, 4th ed. New York: Springer-Verlag, 1992.
17. Pinkel, D., Straume, T. and Gray, J. W.: Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc. Nat. Acad. Sci., 83: 2934, 1986.
18. Oud, P. S., Henderik, J. B., Huysmans, A. C., Pahlplatz, M. M., Hermkens, H. G., Tas, J., James, J. and Vooijs, G. P.: The use of Light Green and Orange II as quantitative protein stains, and their combination with the Feulgen method for simultaneous determination of protein and DNA. Histochemistry, 80: 49, 1984.
19. Koss, L. G.: Diagnostic Cytology and its Histopathologic Bases, 4th ed. Philadelphia: J. B. Lippincott Co., vol. 1, chapt. 35, pp. 1596-1600, 1992.
20. Cairns, P., Shaw, M. E. and Knowles, M. A.: Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9. Oncogene, 8: 1083, 1993.